P073-0477 Screening compound: 3-methyl-N-(2-{1-[(4-methylphenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)butanamide

P073-0477 Screening compound: 3-methyl-N-(2-{1-[(4-methylphenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)butanamide
P073-0477 Screening compound: 3-methyl-N-(2-{1-[(4-methylphenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P073-0477
3-methyl-N-(2-{1-[(4-methylphenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P073-0477

Molecular Formula

C21H26N4O2 (C21 H26 N4 O2)

Compound Name

3-methyl-N-(2-{1-[(4-methylphenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)butanamide

IUPAC name

3-methyl-N-(2-{1-[(4-methylphenyl)methyl]-2-oxo-1H2H3H-imidazo[45-b]pyridin-3-yl}ethyl)butanamide

SMILES

CC(C)CC(NCCN(c(nccc1)c1N1Cc2ccc(C)cc2)C1=O)=O

InChI

InChI=1S/C21H26N4O2/c1-15(2)13-19(26)22-11-12-24-20-18(5-4-10-23-20)25(21(24)27)14-17-8-6-16(3)7-9-17/h4-10,15H,11-14H2,1-3H3,(H,22,26)

InChI Key

VRWMAGBXBFHNJX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27562417

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

366.46

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.421

Distribution Coefficient, logD

3.421

Water Solubility, LogSw

-3.47

Polar Surface Area

52.742

Acid Dissociation Constant (pKa)

14.66

Base Dissociation Constant (pKb)

1.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.10

P073-0477 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Angiogenesis library (14822 compounds)

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P073-0477 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P073-0477?
Check Price and Availability of P073-0477, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P073-0477 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P073-0477
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P073-0477
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P073-0477 available by request